> The FDA has accepted Centocor's marketing application for Remicade as a treatment for psoriatic arthritis. Report
> AEterna Zentaris says it plans to file an INDA with the FDA to launch a Phase III trial of cetrorelix as a therapy for benign prostatic hyperplasia. Report
> Schering-Plough is shaking up its marketing efforts in Brazil. Report
> New River Pharmaceuticals has provided details on its A02 clinical abuse liability study of NRP104 at the annual meeting of the College on Problems of Drug Dependence. Report
And Finally... Researchers have used stem cell technology to enable paralyzed rats to walk again. Article